RareCan appoints Dr Anita Cooper as Non-Executive Director
- RareCan
- July 28, 2021
- 1:31 pm
Hexham, UK, 2nd August 2021: RareCan, a new and innovative company accelerating research into rare cancers, today announced the appointment of Dr Anita Cooper as Non-Executive Director. The appointment strengthens the scientific and pharmaceutical experience of RareCan’s Board in support of the company’s planned commercial growth.
Anita is a recognised leader within the pharmaceutical and life sciences sector. With over 30 years’ global business experience, Anita has worked across diverse functions, skill levels and geographies, including strategy development and implementation, risk management, operations and technology-enabled process transformation across the US, Latin America, Europe, India, Japan, South Korea, Taiwan and China. She is currently a Non-Executive Director for Simbec-Orion, a leading Clinical Research Organisation with specialist expertise in clinical pharmacology, oncology, and rare diseases. Prior to this, she served as an Executive Officer and Senior Vice-President of Parexel, a US based, global pharmaceutical services company.
Anita holds an M.A. Honours degree in Psychology from St. Andrews University and a D.Phil. in Experimental Psychology from St. John’s College, Oxford.
Piers Kotting, CEO of RareCan, commented, ‘We are thrilled to welcome Anita to the Board of RareCan. Anita’s wealth of industry experience will help us to accelerate rare cancer research by maximising the value of RareCan to both the global life sciences and pharmaceutical services industries.’
Dr Anita Cooper, Non-Executive Director, RareCan, added, ‘I wholeheartedly agree with RareCan’s company values, which focus on integrity, impact, trust, being brave and determined on behalf of patients and being inclusive. I see a huge opportunity to increase the potential for better patient outcomes, by connecting people diagnosed with rare cancers with passionate researchers and facilitating data exchange to enable, enhance and speed research to support diagnostic and therapeutic advances. I will work with the RareCan team to contribute to this important endeavour.’
Anita’s appointment follows the news that RareCan has been shortlisted for Start Up Entrepreneur of the Year at the 2021 Great British Entrepreneur Awards for the NorthEast region. The awards celebrate and champion the entrepreneurs behind brilliant businesses. Winners will be announced in September.
